Biogen Inc. buy The Goldman Sachs Group, Inc.
Start price
08.01.26
/
50%
€160.80
Target price
08.01.27
-
Performance (%)
-6.67%
Price
12:11
€150.08
Summary
This prediction is currently active. With a performance of -6.67%, the BUY prediction by The_Goldman_Sachs_Gr is trending in the wrong direction. This prediction currently runs until 08.01.27. The prediction end date can be changed by The_Goldman_Sachs_Gr at any time. The_Goldman_Sachs_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Biogen Inc. | -1.282% | -1.282% |
| iShares Core DAX® | 0,79 % | 1,97 % |
| iShares Nasdaq 100 | 4,23 % | 4,34 % |
| iShares Nikkei 225® | 3,29 % | 6,99 % |
| iShares S&P 500 | 2,50 % | 2,76 % |
Comments by The_Goldman_Sachs_Gr for this prediction
In the thread Biogen Inc. diskutieren
Biogen (NASDAQ:BIIB) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Ratings data for BIIB provided by MarketBeat